Results 101 to 110 of about 756,852 (217)

Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series [PDF]

Yuan Zhang,1,* Zheyu Fang,1,* Yaping Liu,2,* Bingbing Wan,1 Qiaoyi Zhang,1 Xi Qu,1 Shengli Pan,1 Yu Zhang,1 Yilin Dai,1 Shiyin Yang,1 Jia Li,1 Xu Zhang1 1Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University ...
Liu Y, Wan B, Fang Z, Li J, Pan S, Zhang Y, Zhang X, Qu X, Yang S, Zhang Q, Dai Y   +10 more
core  

Efgartigimod-alfa therapy in acetylcholine receptor antibody myasthenia gravis: Romanian experience

Frontiers in Neurology
BackgroundEfgartigimod alfa, the first neonatal Fc receptor inhibitor approved for the treatment of acetylcholine receptor antibody (AChR)-positive generalized myasthenia gravis (MG), has demonstrated efficacy in randomized controlled trials.
Nicolae Grecu, Oana Antonia Mihalache, Eugenia Irene Davidescu, Eugenia Irene Davidescu, Rodica Bălașa, Rodica Bălașa, Mihaela Simu, Mihaela Simu, Mihaela Simu, Vitalie Văcăraș, Vitalie Văcăraș, Ileana-Maria Vodă, Andreea-Ioana Mușuroi, Andra Mădălina Ene, Diana Mihaela Petrescu, Cristina Elena Mitu, Lorena Furnică, Lorena Furnică, Amalia Cornea, Amalia Cornea, Romana Homorodean, Crisanda Vîlciu, Crisanda Vîlciu, Cristina Tiu, Cristina Tiu   +24 more
doaj   +1 more source

Myasthenia gravis and preeclampsia: Dot all the I's and cross all the T's

Journal of Taibah University Medical Sciences, 2017
Although rare, the co-occurrence of myasthenia gravis and preeclampsia during pregnancy is responsible for considerable maternal and foetal morbidity and mortality.
Ali Hassan, FCPS
doaj   +1 more source

Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report [PDF]

, 2014
INTRODUCTION Myasthenia gravis is an autoimmune disease characterized by fluctuating muscle weakness. It is often associated with other autoimmune disorders, such as thyroid disease, rheumatoid arthritis, systemic lupus erythematosus, and ...
Clair, Carole, Diana Dan, Kuntzer, Thierry, Thierry Kuntzer, Bart, Pierre-Alexandre, Dan, Diana Camelia, Pierre-Alexandre Bart, Jan Novy, Carole Clair, Novy, Jan   +9 more
core   +3 more sources

Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod

Frontiers in Immunology
There is always a lack of effective treatment for highly active refractory generalized myasthenia gravis (GMG). Recently, telitacicept combined with efgartigimod significantly reduces circulating B cells, plasma cells, and immunoglobulin G, which brings ...
Chaoyue Zhang, Yangtao Lin, Qianjin Kuang, Hongjin Li, Qilong Jiang, Xiaojun Yang   +5 more
doaj   +1 more source

Acetylcholine receptor antibody in the diagnosis of myasthenia gravis

, 1983
The acetylcholine receptor (AchR) antibody assay has a key role in the diagnosis of myasthenia gravis. In this article, the role of AchR antibody assay in the diagnosis of ocular and generalized myasthenia gravis is reviewed, and compared to standard ...
Nicholson, G. A., Griffiths, Lyn R., McLeod, J. G.   +2 more
core  

Conversion Rate Of Ocular Myasthenia Gravis To Generalized Myasthenia Gravis

, 2013
Ocular myasthenia gravis (OMG) is a common presentation to the neuro-ophthalmology clinic. Previous studies have reported that generalized myasthenia gravis (GMG) develops in 50% or more of patients presenting with OMG, usually within 2 years.
Lina Nagia; Khawla Abusamra; Eric R. Eggenberger
core  

Comparison of diagnostic tests in myasthenia gravis

, 1983
Results of 3 tests, intravenous edrophonium chloride, EMG, and acetylcholine receptor antibody testing, were compared in patients with generalised and ocular myasthenia gravis.
Nicholson, G. A., Griffiths, Lyn R., McLeod, J. G.   +2 more
core  

A personalized approach to the treatment of generalized myasthenia gravis

Generalized myasthenia gravis is a chronic autoimmune disorder characterized by an attack on the structures of the neuromuscular junction and by fluctuating muscle weakness and pathological fatigue, involving the ocular, bulbar, respiratory and skeletal ...
D. I. Rudenko, O. V. Boyko, D. S. Kasatkin, O. V. Gilvanova, T. M. Alekseeva, N. A. Marskaya   +5 more
core   +1 more source

A case report of sequential efgartigimod and rituximab treatment for tSNMG

Frontiers in Immunology
Trible‐seronegative myasthenia gravis (tSNMG) is defined as myasthenia gravis (MG) without detectable or low affinity antibodies to acetylcholine receptor (AChR), muscle‐specific kinase (MuSK) andlipoprotein related protein 4(LRP-4). This article reports
Hua Xie, Ting Ting Pan, Lin Zhang, Lin Zhang   +3 more
doaj   +1 more source